Search
-
[WEBINAR] Understanding Category Trends in the Age of the Consumer
Sept 14 - Staying ahead of trends in today’s rapidly shifting landscape is more important and more complex than ever before. In a world where ideas and influence can spread like wildfire, how do we better equip ourselves with the category understanding and depth of knowledge essential to success?
-
[EVENT] #ANAMetrics
On September 13, Ipsos is delighted to be a sponsor of the 2017 ANA Data & Measurement Conference presented by Google.
-
[EVENT] NASPL Annual Conference
On September 13, join Ipsos at this year’s annual NASPL conference focused on helping you navigate the rapidly shifting lottery environment.
-
[EVENT] Insights for Connected Living
September 7 - What if you could use cognitive technology to navigate and integrate all of your complex databases and information systems without ever losing sight of the fundamental human insights?
-
Europe Affluent and Their Cars: the Unexpected Truth
Affluent who own 4+ cars are the ones who get most out of life. Luxury car owners are not by definition the happiest in life.
-
Ipsos Update - August 2017
Welcome to the August edition of Ipsos Update – our monthly selection of research and thinking from Ipsos teams around the world.
-
Designing a ‘Smarter’ Mystery Shopping Program
Seven Steps to Success - Countless research studies show that brands which put the customer first and deliver a superior experience relative to their competition, achieve greater customer loyalty, higher profits and better returns for shareholders.
-
Brazil Pulse - 85% of Brazilians Consider the Michel Temer's Administration bad - July 2017
The country is still heading in the wrong direction for 95% of Brazilians, repeating last month’s result. This decline of the confidence in Brazil lifted off in January 2015 and stabilized at extremely high levels since then.
-
Ipsos Healthcare adds Hidradenitis Suppurativa (HS) to Global Therapy Monitor Portfolio
Ipsos Healthcare, the global healthcare division of Ipsos, has launched the Hidradenitis Suppurativa (HS) Therapy Monitor in the EU5. The HS Monitor, part of Ipsos’ Autoimmune Real World Evidence portfolio, launched in the EU5 in Q2 of 2017, with plans to extend to other markets.